UNSPSC 41142042: Pregnanetriol test system

In this classification, Pregnanetriol test system connotes a device used to measure Pregnanetriol levels. US FDA regulates Pregnanetriol test system under 21 CFR 862.16100 and under FDA product code JLR.

UNSPSC 41142042 Pregnanetriol test system, a Commodity code, encompasses diagnostic reagent kits and certified reference materials for forensic and clinical laboratory analysis, including direct ELISA testing kits for controlled-substance screening, West Nile Virus and Dengue test kits, and certified drug standards for toxicology and seized-drug analysis. State and local governments buying under this code are primarily law enforcement agencies, forensic laboratories, and public health departments. The Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission, the Illinois Department of Financial and Professional Regulation, Pinellas County Florida, and the Florida Department of Law Enforcement have all posted solicitations for these materials within the past four months. Issuers range from state forensic crime labs to county forensic laboratories and multi-jurisdictional public health procurement entities establishing master contracts for statewide or multistate use.

Recent activity clusters in Texas and Florida, with Illinois establishing cooperative purchasing vehicles for national distribution. Representative opportunities include the Texas Department of Public Safety's July 2026 IFB 405-26R0008445A for Direct ELISA substance-analysis reagent kits (12 line items, due July 23, 2026); the Illinois Department of Financial and Professional Regulation's May 2026 sole-source joint purchase master contract for RAMP mosquito-borne virus test kits through ADAPCO, LLC (due May 20, 2026); Pinellas County's April 2026 Invitation to Quote 26-0305-ITQ for 131 line items of certified drug standards totaling $72,126.85 in federal funding with five-year record retention and SBE preference (due April 23, 2026); and the Texas Health and Human Services Commission's February 2026 IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits with historical spend of $25,050 to $30,000 annually (bid due January 29, 2026, anticipated contract start January 30, 2026). HUB subcontracting plans and SBE preferences appear in Texas and Florida solicitations; sole-source and notice-of-intent-to-award pathways are active alongside competitive IFB processes.